Home Pharmaceuticals Tendonitis Treatment Market Segmentation, Demand, Growth, Forecast to 2030

Tendonitis Treatment Market

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapeutic Treatment, Hot and Cold Therapy, Physical Therapy, Shockwave Therapy, Surgical Treatment), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Swimmer's Shoulder, Achilles Tendonitis) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRPH1991DR
Study Period 2018-2030 CAGR 3.27%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 193.03 Billion
Forecast Year 2030 Forecast Year Market Size USD 257.87 Billion
Largest Market Asia Pacific Fastest Growing Market North America
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The Global Tendonitis Treatment Market was valued at USD 193.03 billion in 2021 and is predicted to reach at USD 257.87 billion by 2030, increasing at a CAGR of 3.27% from 2022 to 2030.

When the tendon, which is a flexible but inelastic cord of tissue linking the bone to the muscle, becomes inflamed or irritated, a condition known as tendonitis is diagnosed. Tendonitis is an acute ailment. Pain, decreased mobility, and decreased muscular strength are just some of the potential side effects of tendonitis, which is an inflammation of the tendon that can be caused by tendinitis. Tenderness, frozen shoulder, and slight swelling are some of the symptoms that are connected with tendonitis.

Tendonitis can affect various regions of a person's body, including the knees, elbows, heels, shoulders, the base of the thumbs, the Achilles tendon, and the wrists. Some of the different kinds of tendonitis are referred to by their common names, such as swimmer's shoulder, golfer's elbow, tennis elbow, and jumper's knee. Tendonitis can be caused by a variety of factors, including abrupt injuries sustained during exercise or while performing occupational duties. However, those most at risk of developing the condition are older people, particularly those who participate in sports. In order to avoid tendon ruptures and the condition known as tendinosis, which is a degenerative condition, tendonitis needs to be treated properly. If it is not treated properly, tendonitis can lead to tendonitis.

Market Dynamics

Market Drivers

The Market Will Grow as The Number of Sports-Related Injuries Rises

Sports-related injuries are becoming more common as a result of the rapid increase in sports activities, which is a leading cause of soft tissue injuries globally and a major market driver. The number of people choosing sports as a career or pastime has increased as work opportunities and a desire for physical fitness have increased. It's likely to increase their chances of getting hurt. Achilles tendinopathy affects 40.0 percent to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University.

Tendonitis is becoming more common in the general population (5-10 cases per 100,000), which is expected to fuel the market for tendonitis treatment. The number of patients seeking treatment has increased as the penetration of various treatment options such as physical therapy, over-the-counter pain relievers, and surgical procedures has increased, driving market growth. Because eccentric strengthening is a particularly successful treatment for persistent tendon disorders, physical therapy has proven to be the first-line treatment for tendonitis. In the forecasted timeframe, these factors are driving market expansion.

An Increase in The Number of Cases as The Population Becomes Older

Tendonitis is a medical disorder in which a tendon, a thick fibrous cord that connects muscle and bone, becomes inflamed or infected. The older the population, the more likely it is to suffer from this ailment. As the world's ageing population grows, the worldwide tendonitis treatment market is expected to see potential growth possibilities in the years to come.

It is a well aligned connective tissue that permits the passage of force from muscles to bone. There are an estimated 32.0 million tendon injuries reported each year on average. The ageing population has contributed to an increase in the incidence of tendinopathies, which now account for 50 percent of all sports-related injuries. A major factor in the growth of the global Tendonitis Treatment Market is this.

Market Restraints

Growth Constraints and Pandemic's Harmful Effects

Tendonitis treatment is hindered by the recurrence of injuries, the lack of efficacy and speed of treatments, as well as the related adverse effects. Because of the Covid-19 epidemic, the way tendinitis is treated has changed significantly. The market has been badly impacted by the temporary lockdowns, travel restrictions, and increased infection load in the healthcare facilities. The pandemic has been slowed down by a lack of qualified healthcare workers who can treat tendinitis. Sports injury cancellations or postponements imply a decrease in sports injury numbers, which has a negative impact on business revenue. Non-pharmacological therapy and operations are on the decline, which is limiting market expansion. Market growth is being held back by the recurrence of abrupt injuries, the treatment-related adverse effects, and extended inactivity, which can lead to stiff joints, among other things.

Market Key Future Opportunities

The Proliferation of Different Sporting Activities Creates Brand New Chances

There has been a noticeable increase in the proportion of the general public that takes part in sporting activities, which correlates with the growing propensity of the majority of the people to embrace a healthier way of life. Putting this to the side, there has been a notable increase in the number of individuals who are considering a career in sports. These factors have led to an increase in the number of sporting events that are held all over the world, which has led to an increase in the likelihood that athletes would sustain injuries linked to their sport. It is projected that businesses currently active in the global tendonitis treatment market will be able to capitalize on profitable new avenues made available as a result of this scenario. This will be a key reason for new opportunities in the market.

Regional Analysis

The Global Tendonitis Treatment Market is segmented by geography into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

In Asia-Pacific, due to the increasing number of tendinitis surgeries conducted in the region as well as rising levels of disposable income, Asia Pacific dominated the market for tendonitis treatment and accounted for the greatest revenue share of about 71 percent in 2021. There are tremendous prospects for expansion in the tendinitis treatment market in the region as a result of both the increasing penetration of local producers of medical devices and the growing number of people who need treatment for tendonitis. Additionally, other significant drivers that are driving the market include ongoing research in this field, an increase in the number of medicines in the pipeline for tendonitis treatment, notably in China and Japan, and an increase in the number of injuries that are caused by sports.

It is expected that Lain America would record the highest CAGR of 3.87 percent throughout the course of the forecast year. One of the primary factors contributing to the expansion of the tendinitis market is the existence in Latin America of a sizable number of medical facilities and hospitals that provide tendonitis patients with surgical treatments and therapeutic options. In order to develop innovative treatment protocols with a primary emphasis on providing high-quality care to patients, a number of highly esteemed surgeons, physicians, and other medical professionals from a variety of other countries have collaborated with regional hospitals in Latin American countries.

In North America, there will also be a large growth due to the presence of big players and higher expenditures on advances in healthcare. This will cause the market to expand significantly. In comparison to other locations, there has been a greater increase in the population's awareness of the condition in North America. The global market for tendonitis treatment is projected to grow in North America due to the region's well-established healthcare facilities, its rising senior population, and its rising number of orthopedic surgeries.

In Europe, however, it is anticipated that the market will grow as a result of the growing incidence of sports injuries and tendinitis, as well as the emerging criteria that have been given forth by the government for the treatment of tendonitis.

Report Scope

Report Metric Details
By Treatment
  1. Therapeutic Treatment
  2. Hot and Cold Therapy
  3. Physical Therapy
  4. Shockwave Therapy
  5. Surgical Treatment
By Condition
  1. Tennis Elbow
  2. Golfer's Elbow
  3. Pitcher's Elbow
  4. Jumper's Knee
  5. Swimmer's Shoulder
  6. Achilles Tendonitis
Company Profiles AstraZeneca AKSIGEN Boehringer Ingelheim Pharmaceuticals, Inc. Abbott Merck and Co., Inc. Pfizer 3M Bayer AG GlaxoSmithKline PLC Teikoku Pharma USA Inc. DJO Global Inc. Almatica Pharma, Inc. Teva Pharmaceuticals Industries Zimmer Biomet
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The Global Tendonitis Treatment Market is divided into different segments according to the Treatment, the Condition and the Region (or geographies).

By Treatment

The Global Tendonitis Treatment Market is segmented into Therapeutic treatment and Surgical treatment. Therapeutic treatment dominated the market for tendinitis treatment in 2021, accounting for almost 75% of sales. Non-invasive therapy is preferred by target patients over surgical techniques for tendonitis treatment. Because physical therapy was the first line of treatment, it has the largest market share. Other types of therapy, such as heat and cold therapy and shockwave therapy, have seen a significant increase in demand.

NSAIDs are used as a first-line treatment for tendinitis, in conjunction to physical therapy. Surgery is the last resort for tendonitis treatment in cases of severe tendon injury that cannot be treated with pharmaceutical treatments. In the first 48 hours after injury, cold therapy, particularly cold compresses, is frequently beneficial. Tendonitis treatment options differ depending on the cause. Achilles Because the Achilles tendon is the largest in the body, tendinitis is the most common type of tendonitis.

By Condition

The Global Tendonitis Treatment Market is segmented into Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Swimmer's Shoulder, and Achilles tendonitis. Achilles tendonitis led the market in 2021, because to its rising incidence among athletes. According to the NCBI article 'Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People,' the lifetime incidence of Achilles Tendonitis in athletes is anticipated to be 25% by 2021. The incidence of Achilles tendinopathy in elite adolescent athletes is only 1.0 percent, compared to 10% in leisure players. Acute and chronic cases of Achilles tendinitis are treated with a combination of conservative and surgical techniques. Professionals strongly advise surgical treatment in cases of complete rupture.

Because of the rising occurrence of medial and lateral elbow tendinopathy, the golfer's elbow sector is predicted to grow the fastest. According to a report published by the National Center for Biotechnology Information in May 2018, golfer's elbow strikes men and women equally between the ages of 45 and 65. As a result, the growing senior population and changing lifestyles, which favor physical and sporting activities, contribute to the growth of elbow tendinopathy, which is driving the industry forward.

By Region

The Global Tendonitis Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Due to an increase in the number of tendonitis surgeries in the region and rising disposable income, Asia Pacific dominated the market for tendinitis therapy in 2021, accounting for about 71 percent of revenue.

During the projection period, Lain America is expected to have the fastest CAGR of 3.87 percent. One of the key drivers of market expansion is the large number of medical facilities and hospitals in Latin America that provide tendonitis operations and treatments.

Market Size By Treatment

Recent Developments

  • December 2021 - An exoskeleton knee brace that is about 30% lighter than standard models was developed by Delsson, a Singapore-based engineering firm, in partnership with 3D printing experts at Nanyang Technological University (NTU) in Singapore, in December 2021.
  • July 2021 - Clinical-stage cell therapy and regenerative medicine company InGeneron Inc. announced in July 2021 that it had published results of the world's first comprehensive immunohistochemical evaluation of adult tendon repair following local injection of fresh, uncultured and undamaged autologous cells from adipose tissue (UA-ADRCs).

Top Key Players

AstraZeneca AKSIGEN Boehringer Ingelheim Pharmaceuticals, Inc. Abbott Merck and Co., Inc. Pfizer 3M Bayer AG GlaxoSmithKline PLC Teikoku Pharma USA Inc. DJO Global Inc. Almatica Pharma, Inc. Teva Pharmaceuticals Industries Zimmer Biomet Others

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the Tendonitis Treatment Market?
Tendonitis Treatment Market size will grow at approx. CAGR of 3.27% during the forecast period.
Some of the top prominent players in Tendonitis Treatment Market are, AstraZeneca, AKSIGEN, Boehringer Ingelheim Pharmaceuticals, Inc., Abbott, Merck and Co., Inc., Pfizer, 3M, Bayer AG, GlaxoSmithKline PLC, Teikoku Pharma USA Inc., DJO Global Inc., Almatica Pharma, Inc., Teva Pharmaceuticals Industries, Zimmer Biomet, etc.
Asia Pacific has held a dominant position in the Tendonitis Treatment Market, with the largest market share.
The North America region is projected to exhibit the highest rate of growth in the Tendonitis Treatment Market.
The global Tendonitis Treatment Market report is segmented as follows: By Treatment, By Condition

We are featured on :

This website uses cookies to ensure you get the best experience on our website. Privacy Policy